Digital health is the new front door to clinical trials.
Millions of Americans receive care online. Eureka turns digital health platforms into a powerful recruiting channel.
Access patient populations others don't have access to
Insights tailored to your trial, stage by stage — so every future campaign recruits better than the last
Resolved to a reported outcome. No silent handoffs.
Trial recruitment hasn't caught up.
of trials miss their enrollment timeline
JMIR systematic review, 2020
lost revenue per day of trial delay
Tufts CSDD, 2024
screen-fail rate in Phase II/III — and rising
Tufts CSDD
miss enrollment targets. 11% of sites enroll zero, 37% under-enroll
Tufts CSDD
Without Eureka, physicians refer fewer than 1% of their patients to a trial.
Eureka aligns incentives and builds referral into digital care workflows.
Patients moved online. Recruitment hasn't changed.
| Site databases | Digital advertising | EHR screening tools | Eureka | |
|---|---|---|---|---|
| Reaches patients managed outside health systems | ||||
| Targeting uses current clinical data | ||||
| Outreach comes from the teams caring for the patient | ||||
| Funnel data returned by stage | ||||
| Outcome reported after handoff |
Eureka is the digital health-native bridge between highly-engaged online patient pools and the research teams that want to reach them.
Eureka supports the CROs and site networks you already have in place.
Patients qualified before a coordinator ever calls.
Screen failures are increasingly expensive. Eureka's patients arrive condition-identified, pre-screened against your protocol, and affirmatively consented — so the screening visit tests eligibility, not whether the patient was ever plausible.
Engaged patients no other channel can see.
Millions of patients now manage their condition entirely outside the hospital system. They are invisible to EHR-mining and outside every site catchment. Eureka reaches them inside the platform they already trust.
Days back on the critical path.
Around 80% of trials miss enrollment timelines, and each day of delay costs roughly $800K in deferred revenue.
A funnel you can forecast against.
Conversion by funnel step, time-to-screen versus baseline, and screen-fail mapped to criterion. Insights compound with every trial.
Oversight without custody.
See what happened to every referral — screened, enrolled, declined, and how long each took. The right data goes to the right teams.
The referral chain of custody.
Blind match
Platforms embed Eureka’s matching AI. The AI surfaces relevant trials for their patient population.
Patient outreach
Patients learn about trials that are relevant for them and complete pre-screening in situ.
Screen and consent
Patients who don’t match stay in the pool for future trials.
Transfer
Consented and pre-screened patients go to the sponsor-designated trial teams for review.
Gated disposition
Eureka collects status on every referral, with screen-fails mapped to I/E criteria.
Every referral is answered.
With Eureka, a referral cannot be ignored — every patient gets a response and all eligibility decisions are contextualized.
No ghosted patients
No referral disappears. Every patient receives a response and is kept engaged for future trials.
Self-writing evidence
Every referral returns an outcome, with context.
Matching that learns
Criterion-level outcomes feed back in. Every trial sharpens the next match.
Protocol intelligence
Real-time data that shows which criteria choke enrollment.